Gyre Therapeutics Inc
NASDAQ:GYRE

Watchlist Manager
Gyre Therapeutics Inc Logo
Gyre Therapeutics Inc
NASDAQ:GYRE
Watchlist
Price: 7.21 USD -2.44% Market Closed
Market Cap: 635.2m USD

Wall Street
Price Targets

GYRE Price Targets Summary
Gyre Therapeutics Inc

Wall Street analysts forecast GYRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GYRE is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.

Lowest
Price Target
20.2 USD
180% Upside
Average
Price Target
20.4 USD
183% Upside
Highest
Price Target
21 USD
191% Upside
Gyre Therapeutics Inc Competitors:
Price Targets
301047
Sino Biological Inc
11% Upside
MDXG
MiMedx Group Inc
91% Upside
301080
Acrobiosystems Co Ltd
20% Downside
EDIT
Editas Medicine Inc
25% Upside
VNDA
Vanda Pharmaceuticals Inc
170% Upside
FLUO
Fluoguide AS
163% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
36% Upside
KRYS
Krystal Biotech Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Gyre Therapeutics Inc

For the last 8 years the compound annual growth rate for Gyre Therapeutics Inc's revenue is 101%. The projected CAGR for the next 3 years is 51%.

101%
Past Growth
51%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gyre Therapeutics Inc

The compound annual growth rate of Gyre Therapeutics Inc's operating income for the next 3 years is 130%.

N/A
Past Growth
130%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Gyre Therapeutics Inc

The compound annual growth rate of Gyre Therapeutics Inc's net income for the next 3 years is 134%.

N/A
Past Growth
134%
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GYRE's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for GYRE is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.

What is Gyre Therapeutics Inc's Revenue forecast?
Projected CAGR
51%

For the last 8 years the compound annual growth rate for Gyre Therapeutics Inc's revenue is 101%. The projected CAGR for the next 3 years is 51%.

What is Gyre Therapeutics Inc's Operating Income forecast?
Projected CAGR
130%

The compound annual growth rate of Gyre Therapeutics Inc's operating income for the next 3 years is 130%.

What is Gyre Therapeutics Inc's Net Income forecast?
Projected CAGR
134%

The compound annual growth rate of Gyre Therapeutics Inc's net income for the next 3 years is 134%.

Back to Top